Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CDXS
#3601
Codexis, Inc.
2.3
7
USD
+3.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.04%
Monthly Change
+46.30%
6 month change
-7.78%
Year Change
+4.41%
Previous Close
2.3
0
Open
2.3
7
Bid
Ask
Low
2.3
7
High
2.3
7
Volume
55
Markets
US Stock Market
Healthcare
CDXS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
64.4 M
65.16 M
65.95 M
70.3 M
82.84 M
90.87 M
—
Valuation ratios
Enterprise value
1.26 B
1.92 B
193.99 M
154.23 M
435.76 M
170.53 M
960.7 M
Price to earnings ratio
—
-94.76
-9.16
-2.79
-5.36
-3.26
-12.23
Price to sales ratio
—
19.27
2.2
3.03
5.9
2.02
13
Price to cash flow ratio
—
-141.52
27.04
-4.04
-7.09
-7.33
-17.61
Price to book ratio
—
12.28
2.11
2.45
5.23
2.81
5.31
Enterprise value to EBITDA ratio
-57.1
-94.77
-6.57
-2.85
-7
-2.66
-13.18
Profitability ratios
Return on assets %
-0.11
-0.09
-0.13
-0.56
-0.44
-0.3
-0.35
Return on equity %
-0.14
-0.13
-0.23
-0.88
-0.98
-0.87
-0.97
Return on invested capital %
-178.54
-105.71
-121.25
-292.59
-347.64
-241.41
-264.45
Gross margin %
80.04
78.47
72.52
81.74
72.55
86.73
316.18
Operating margin %
-34.64
-21.67
-25.17
-97.04
-98.61
-59.3
-548.68
EBITDA margin %
-31.87
-19.35
-21.31
-77.17
-90.44
-52
-506.34
Net margin %
-34.77
-20.31
-24.24
-108.69
-109.99
-62.47
-564.24
Liquidity ratios
Quick ratio
7.34
4.82
3.28
2.53
4.1
3.75
17.1
Current ratio
7.38
4.85
3.32
2.61
4.18
3.82
17.49
Inventory turnover
20.59
20.91
23.85
5.43
7.26
5.16
5.01
Asset turnover
0.37
0.45
0.56
0.36
0.42
0.47
0.52
Solvency ratios
Debt to assets ratio
—
—
—
—
0.4
0.5
2.01
Debt to equity ratio
—
—
—
—
0.89
1.45
5.67
Long term debt to total assets ratio
—
—
—
—
0.19
0.27
1.1
Long term debt to total equity ratio
—
—
—
—
0.43
0.79
3.12
Per share metrics
Operating cash flow per share
—
-0.22
0.17
-0.77
-0.67
-0.22
-0.23
EBIT per share
—
-0.35
-0.53
-1
-0.8
-0.48
-0.49
EBITDA per share
—
-0.31
-0.45
-0.79
-0.73
-0.42
-0.43
Total debt per share
—
—
—
—
0.82
0.84
3.13
Cash per share
—
1.81
1.74
0.96
1
0.9
3.05
Net current asset value per share
—
2.51
2.49
1.37
1.35
1.11
3.94
Tangible book value per share
—
2.5
2.17
1.24
0.88
0.55
2.15
Working capital per share
—
1.99
1.74
0.85
1.02
0.82
3.01
Book value per share
—
2.55
2.22
1.27
0.91
0.58
2.26
Codexis Inc
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
News
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS)
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Codexis (NASDAQ:CDXS)
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Codexis earnings beat by $0.15, revenue topped estimates
Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates
Codexis signs deal to produce siRNA for pharma partner
Codexis at TD Cowen Conference: Strategic Shift to RNA Medicines
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue Estimates